Regulation of Glycolysis by Non-coding RNAs in Cancer: Switching on the Warburg Effect
- PMID: 33251334
- PMCID: PMC7666327
- DOI: 10.1016/j.omto.2020.10.003
Regulation of Glycolysis by Non-coding RNAs in Cancer: Switching on the Warburg Effect
Abstract
The "Warburg effect" describes the reprogramming of glucose metabolism away from oxidative phosphorylation toward aerobic glycolysis, and it is one of the hallmarks of cancer cells. Several factors can be involved in this process, but in this review, the roles of non-coding RNAs (ncRNAs) are highlighted in several types of human cancer. ncRNAs, including microRNAs, long non-coding RNAs, and circular RNAs, can all affect metabolic enzymes and transcription factors to promote glycolysis and modulate glucose metabolism to enhance the progression of tumors. In particular, the 5'-AMP-activated protein kinase (AMPK) and the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathways are associated with alterations in ncRNAs. A better understanding of the roles of ncRNAs in the Warburg effect could ultimately lead to new therapeutic approaches for suppressing cancer.
Keywords: Warburg effect; cancer; glycolysis; non-coding RNAs.
© 2020 The Author(s).
Figures




References
-
- Warburg O. On the origin of cancer cells. Science. 1956;123:309–314. - PubMed
-
- Warburg O. The chemical constitution of respiration ferment. Science. 1928;68:437–443. - PubMed
-
- Fantin V.R., St-Pierre J., Leder P. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell. 2006;9:425–434. - PubMed
-
- Nguyen T.-L., Durán R.V. Glutamine metabolism in cancer therapy. Cancer Drug Resist. 2018;1:126–138.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous